top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
Ariel Victorio
ASGCT 2024: A Look at Participating Organizations
The American Society of Gene and Cell Therapy (ASGCT) is currently in full swing, bringing together the brightest minds in gene and cell...
Jul 14, 2023
Rare Pediatric Disease Voucher Program is Being Phased Out by FDA…
Will companies continue to develop new meds for rare pediatric diseases? The FDA will be ending their Rare Pediatric Disease Priority...
Jul 13, 2023
AAIC 2023 (Alzheimer's Association International Conference) - Annual Meeting
Summary: The Alzheimer's Association International Conference is taking place from July 16 - 20, 2023 Abstracts are embargoed until the...
Jul 7, 2023
Biopharma Bite Sized News - July 3rd to 7th 2023
Alzheimer's FDA approval, atopic dermatitis data, new Alzheimer's studies, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor?...
Jun 30, 2023
Biopharma Bite Sized News - June 26th to 30th 2023
Alzheimer's agitation data, clinical hold lifted, new studies planned, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...
Jun 27, 2023
New Era In Alzheimer's Treatments Brings Opportunities
BiopharmIQ Biotech Business & Corp Dev INSIGHTS Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a market...
Jun 24, 2023
Biopharma News - June 19th to 23rd 2023
Acquisitions, rare disease data, gene therapy approval, and more.. Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a...
Jun 22, 2023
Target Company Spotlight: Adicet Bio
Early stage cell therapy company with opportunity for CROs, CMOs, and vendors to establish relationships.
Jun 16, 2023
Biopharma News - June 12th to June 16th 2023
Acquisitions, Alzheimer's data, collaborations, and more.. Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a sales...
Jun 13, 2023
New Era In Alzheimer's Treatments Brings Opportunities
Last week Esai and Biogen (Esai/BIIB) moved a step closer to getting full approval for their Alzheimer Disease (AD) therapeutic, Leqembi...
Jun 9, 2023
Biopharma Weekly News - June 5th to June 9th 2023
Glioblastoma drug to enter clinic, EHA presentations, clinical hold lifted, and more.. Are you a CRO, CMO, or Biopharma vendor?...
May 26, 2023
Biopharma Weekly News - May 22nd to May 26th 2023
NASH Data, ASCO abstracts released, and M&A Activity. Read below for a look at major news from biopharma companies.. 🧬 Verastem Oncology...
May 20, 2023
Recent Advances in NASH Provide Opportunity for CROs and Clinical Sites
Non-alcohol related fatty liver disease (NAFLD) is a global health challenge In the U.S. alone there are ~94 million cases NASH is a...
May 18, 2023
Upcoming Phase 3 Trial Initiations To Watch For
Here's some upcoming phase 3 clinical trials! *not on clintrials gov* 😉 ⚡ 89bio plans to initiate a phase 3 for Pegozafermin to treat...
bottom of page